Pot Stocks Post Roll: Weed Beta (VLNS), Growers vs. Suppliers (GRWG), MedMen (MMEN)


In this week’s edition of the Post Roll Thomas George and Scott Willis survey the coronavirus market carnage!

They examine the market beta of cannabis stocks and Valens (TSXV: VLNS) in particular.

Where’s the value? Growers or Suppliers – shedding light on two under-followed suppliers: GrowGeneration (NASDAQ: GRWG) – & Scotts Miracle Grow (NYSE: SMG).

Lastly Scott outlines the shaky financials of MedMen (CNSX: MMEN).

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Grizzle hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post


The Post Roll: Earnings – Aphria, Organigram, Aurora & Valens

In this edition of The Post Roll, Thomas George and Scott Willis review the flurry of earnings releases in the cannabis sector. Aphria – Winning in Cannabis 2.0 Aphria had


The Post-Roll: Bull Market for Vice (Booze, Smokes and Pot)

    In this weeks episode, we’re talking about vice stocks. With much of the global population stuck indoors, we are already seeing indications of spiking consumption and demand for


Pot Stocks Post-Roll: Who’s Next to Kick the Bankruptcy Bucket?

With two cannabis restructurings announced in one day, it got us thinking. Is the day of reckoning finally here for all the zombie cannabis company’s floating around? So in this

Share via
Copy link
Powered by Social Snap